Guérard Melanie, Andreas Zeller, Erich Koller, Christine Marchand, Martina Müller B, Christian Weile, Franz Schuler, Thomas Singer, Yann Tessier
Pharmaceutical Sciences, Roche Innovation Center Basel, Pharmaceutical Research and Early Development, F. Hoffmann-La Roche, Ltd, Basel, 4070, Switzerland.
Roche Innovation Center Copenhagen A/S, Pharmaceutical Research and Early Development, F. Hoffmann-La Roche, Ltd, Hørsholm, 2970, Denmark.
Environ Mol Mutagen. 2017 Apr;58(3):112-121. doi: 10.1002/em.22076. Epub 2017 Mar 10.
Over the last decade, single stranded oligonucleotides (ON) have gained increased attention as a new drug modality. Because the assessment of genotoxicity risk during early development of pharmaceuticals is essential, we evaluated the potential of locked nucleic acids (LNA)-ONs to induce DNA damage in L5178Y tk cells both with the mouse lymphoma assay (MLA) and the micronucleus test (MNT). Further, the MLA was performed to assess gene and chromosome mutation over 3 and 24h (± metabolic activation). In addition, the MNT was performed to assess, in addition, a potential aneugenic liability. None of the experiments demonstrated a genotoxic effect for the five tested LNA-ONs. We further show data from four proprietary LNA-ONs tested in standard genotoxicity assays in vitro and partially in vivo, which were all negative. In addition, cellular and nuclear uptake of LNA-ONs in L5178Y tk cells was demonstrated. Based on the results presented here as well as in the literature about other representatives of this class, we consider LNA-ONs as generally not DNA reactive and question whether genotoxicity testing of this class of ONs should be required. This is in line with recent recommendation made by the OSWG that extensively assessed the genotoxicity of oligonucleotides. Environ. Mol. Mutagen. 58:112-121, 2017. © 2017 Wiley Periodicals, Inc.
在过去十年中,单链寡核苷酸(ON)作为一种新型药物形式受到了越来越多的关注。由于在药物早期开发过程中评估遗传毒性风险至关重要,我们使用小鼠淋巴瘤试验(MLA)和微核试验(MNT)评估了锁核酸(LNA)-ON在L5178Y tk细胞中诱导DNA损伤的潜力。此外,进行MLA以评估3小时和24小时(±代谢活化)内的基因和染色体突变。另外,进行MNT以评估潜在的非整倍体风险。所有实验均未证明五种测试的LNA-ON具有遗传毒性作用。我们还展示了在体外和部分体内标准遗传毒性试验中测试的四种专利LNA-ON的数据,这些数据均为阴性。此外,还证明了LNA-ON在L5178Y tk细胞中的细胞摄取和核摄取。基于本文呈现的结果以及关于该类其他代表物的文献,我们认为LNA-ON通常不具有DNA反应性,并质疑是否需要对这类ON进行遗传毒性测试。这与寡核苷酸安全工作组(OSWG)最近提出的广泛评估寡核苷酸遗传毒性的建议一致。《环境与分子突变》58:112 - 121,2017年。©2017威利期刊公司。